Neuropace

NeuroPace is a medical technology company specializing in the development of implantable devices to treat neurological disorders, particularly epilepsy. They generate revenue by designing, manufacturing, and selling their flagship product, the RNS® System, which monitors and responds to abnormal brain activity to prevent seizures. Founded in 1997, NeuroPace has made significant strides in neuromodulation technology, receiving FDA approval for the RNS® System in 2013. This innovation has positioned the company as a leader in personalized brain-responsive therapy, making it a pivotal player in the field of neurotechnology.

Recent Posts by Neuropace

1-2 of 2